Suppr超能文献

Syndecan-1可改善小儿心脏手术后严重急性肾损伤的预测。

Syndecan-1 improves severe acute kidney injury prediction after pediatric cardiac surgery.

作者信息

de Melo Bezerra Cavalcante Candice Torres, Castelo Branco Klébia Magalhães, Pinto Júnior Valdester Cavalcante, Meneses Gdayllon Cavalcante, de Oliveira Neves Fernanda Macedo, de Souza Nayana Maria Gomes, Penaforte Kiarelle Lourenço, Martins Alice Maria Costa, Libório Alexandre Braga

机构信息

Hospital do Coração de Messejana, Fortaleza, Ceara, Brazil; Medical Sciences Postgraduate Program, Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Ceara, Brazil.

Hospital do Coração de Messejana, Fortaleza, Ceara, Brazil.

出版信息

J Thorac Cardiovasc Surg. 2016 Jul;152(1):178-186.e2. doi: 10.1016/j.jtcvs.2016.03.079.

Abstract

OBJECTIVE

Acute kidney injury is a common occurrence after pediatric cardiac surgery and is associated with adverse patient outcomes. Syndecan-1 is a biomarker of endothelial glycocalyx damage, and its early increment after surgery can be associated with acute kidney injury.

METHODS

We performed a prospective cohort study with 289 patients aged less than 18 years who underwent cardiac surgery at 1 reference institution. Postoperative plasma syndecan-1 was collected within the first 2 hours after cardiac surgery. Severe acute kidney injury, defined according to Kidney Disease: Improving Global Outcomes stage 2 or 3, doubling of serum creatinine from the preoperative value, or need for dialysis during hospitalization, was the main outcome. Analyses were adjusted for clinical variables and "renal angina index" components (early decrease in estimated creatinine clearance from baseline and increase in percent of intensive care unit fluid overload on the first postoperative day).

RESULTS

Plasma syndecan-1 levels measured early in the postoperative period were independently associated with severe acute kidney injury. The accuracy of postoperative syndecan-1 for the diagnosis of severe acute kidney injury was moderate (area under the curve receiver operating characteristic, 0.77; 95% confidence interval, 0.68-0.85). The addition of syndecan-1 improved the discrimination capacity of a clinical model from 0.80 to 0.86 (P = .004) and improved risk prediction, as measured by net reclassification improvement and integrated discrimination improvement. Postoperative sundecan-1 levels also were independently associated with longer length of intensive care unit and hospital stay.

CONCLUSIONS

Postoperative plasma syndecan-1 is associated with subsequent severe acute kidney injury and poor outcomes among children undergoing cardiac surgery. It may be useful to identify patients who are at increased risk for acute kidney injury after cardiac surgery.

摘要

目的

急性肾损伤是小儿心脏手术后的常见并发症,与不良患者预后相关。Syndecan-1是内皮糖萼损伤的生物标志物,其术后早期升高可能与急性肾损伤有关。

方法

我们在一家参考机构对289例年龄小于18岁接受心脏手术的患者进行了一项前瞻性队列研究。心脏手术后2小时内收集术后血浆Syndecan-1。主要结局为严重急性肾损伤,根据改善全球肾脏病预后组织(KDIGO)2期或3期定义,血清肌酐较术前值翻倍,或住院期间需要透析。分析对临床变量和“肾绞痛指数”成分(术后第一天估计肌酐清除率较基线早期下降和重症监护病房液体超负荷百分比增加)进行了校正。

结果

术后早期测得的血浆Syndecan-1水平与严重急性肾损伤独立相关。术后Syndecan-1诊断严重急性肾损伤的准确性中等(受试者操作特征曲线下面积为0.77;95%置信区间为0.68-0.85)。添加Syndecan-1可将临床模型的辨别能力从0.80提高到0.86(P = 0.004),并改善风险预测,通过净重新分类改善和综合辨别改善来衡量。术后Syndecan-1水平也与重症监护病房和住院时间延长独立相关。

结论

术后血浆Syndecan-1与心脏手术患儿随后的严重急性肾损伤和不良预后相关。识别心脏手术后急性肾损伤风险增加的患者可能有用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验